Target intelligence / Profile preview

Inducible myeloid cell leukemia 1 protein (IML1 (in yeast); in mammals, the canonical homolog is DEPDC5)

Target
IML1 (in yeast); in mammals, the canonical homolog is DEPDC5
Molecular classification
Scaffold protein (core polyprotein within a multimeric complex), Regulatory complex component, GTPase-activating protein complex component (as part of GATOR1 in higher eukaryotes), Other
01

Overview

Inducible myeloid cell leukemia 1 protein (Iml1p) is a scaffold component of the Iml1-Npr2-Npr3 complex in yeast, which regulates autophagy in response to specific nutrient signals, notable for acting under non-nitrogen-starvation conditions[1]. Its function is conserved in higher eukaryotes, where the ortholog DEPDC5 forms a key part of the GATOR1 complex, a negative regulator of the mTORC1 pathway that acts as a GTPase-activating protein towards Rag GTPases, thereby inhibiting mTORC1 in conditions of amino acid starvation[2]. GATOR1/DEPDC5 participates in the regulation of cell growth, metabolism, autophagy, and the transition from mitosis to meiosis in response to the nutrient environment. While essential for nutrient sensing and metabolic homeostasis, Iml1/DEPDC5 is not a classical therapeutic target; however, its pathway is of great interest in cancer, metabolic diseases, and basic research into the mTOR signaling cascade[1][2].

Other names
Iml1pGATOR1 complex subunit Iml1 (in yeast)DEPDC5 (human ortholog)GATOR1 catalytic subunit (in mammalian systems)RANS domain-containing protein (refers to a conserved domain within the protein)GATOR complex component (in higher eukaryotes)
02

Mechanism of action

Not applicable (there are no clinical-stage drugs, but mechanistically, loss-of-function or knockdowns lead to hyperactivation of TORC1 signaling. Therefore, potential mechanisms could involve indirect suppression of mTOR inhibitors or upstream nutrient-sensing regulators in research settings)[2].

03

Biological functions

Negative regulation of TORC1 signaling (Target of Rapamycin Complex 1)Autophagy regulation (specifically under non-nitrogen-starvation conditions)Regulation of cell growth and metabolism in response to amino acid availabilityRegulation of meiotic cell cycle transitions (in yeast and model organisms)
04

Disease associations

Cancer (primarily through its mammalian orthologs and interaction with mTOR pathway; inactivation/dysregulation can contribute to tumorigenesis or metabolic disorders)Other (abnormal function implicated in metabolic regulation and possibly rare disorders associated with mTOR dysregulation)
05

Safety considerations

Loss leads to hyperactive mTORC1, which is associated with increased cell proliferation, metabolic dysregulation, and potentially cancer[2].No direct safety concerns from clinical inhibition/stimulation, as the protein is not a direct therapeutic target[2].
06

Biomarkers

DEPDC5 mutation or expression status (in cancers or metabolic disorders involving mTOR pathway, research use only)Activity or composition of the GATOR1 complex in metabolic and growth regulation studies

Beyond the preview

Go deeper on Inducible myeloid cell leukemia 1 protein (IML1 (in yeast); in mammals, the canonical homolog is DEPDC5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inducible myeloid cell leukemia 1 protein (IML1 (in yeast); in mammals, the canonical homolog is DEPDC5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call